{"id":"https://openalex.org/W2182578436","doi":null,"title":"Access to Medicine Index: Can a global scorecard framework increase access to essential medicines in developing countries?","display_name":"Access to Medicine Index: Can a global scorecard framework increase access to essential medicines in developing countries?","publication_year":2014,"publication_date":"2014-01-01","ids":{"openalex":"https://openalex.org/W2182578436","mag":"2182578436"},"language":"en","primary_location":{"id":"mag:2182578436","doi":null,"is_oa":false,"landing_page_url":"https://sites.duke.edu/sjpp/files/2014/02/Attard-ATMi.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010243041","display_name":"Jamie Attard","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Jamie Attard","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5010243041"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.4908,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.86651932,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":96},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12816","display_name":"Global Public Health Policies and Epidemiology","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pharmaceutical-industry","display_name":"pharmaceutical industry","score":0.5730000138282776},{"id":"https://openalex.org/keywords/access-to-essential-medicines","display_name":"access to essential medicines","score":0.9629999995231628},{"id":"https://openalex.org/keywords/developing-countries","display_name":"developing countries","score":0.8870000243186951},{"id":"https://openalex.org/keywords/stakeholder-engagement","display_name":"stakeholder engagement","score":0.9399999976158142},{"id":"https://openalex.org/keywords/pharmaceutical-companies","display_name":"pharmaceutical companies","score":0.6150000095367432},{"id":"https://openalex.org/keywords/drug-affordability","display_name":"drug affordability","score":0.3840000033378601}],"concepts":[{"id":"https://openalex.org/C2780224610","wikidata":"https://www.wikidata.org/wiki/Q1530061","display_name":"Credibility","level":2,"score":0.7800577878952026},{"id":"https://openalex.org/C199004533","wikidata":"https://www.wikidata.org/wiki/Q210127","display_name":"Balanced scorecard","level":2,"score":0.7314721941947937},{"id":"https://openalex.org/C3019492093","wikidata":"https://www.wikidata.org/wiki/Q29468924","display_name":"Access to medicines","level":3,"score":0.653833270072937},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.6221071481704712},{"id":"https://openalex.org/C83864248","wikidata":"https://www.wikidata.org/wiki/Q177323","display_name":"Developing country","level":2,"score":0.5287318229675293},{"id":"https://openalex.org/C18762648","wikidata":"https://www.wikidata.org/wiki/Q42213","display_name":"Work (physics)","level":2,"score":0.4642212390899658},{"id":"https://openalex.org/C201305675","wikidata":"https://www.wikidata.org/wiki/Q852998","display_name":"Stakeholder","level":2,"score":0.46302974224090576},{"id":"https://openalex.org/C2777382242","wikidata":"https://www.wikidata.org/wiki/Q6017816","display_name":"Index (typography)","level":2,"score":0.4602919816970825},{"id":"https://openalex.org/C2482559","wikidata":"https://www.wikidata.org/wiki/Q206330","display_name":"Objectivity (philosophy)","level":2,"score":0.4484449028968811},{"id":"https://openalex.org/C195094911","wikidata":"https://www.wikidata.org/wiki/Q14167904","display_name":"Process management","level":1,"score":0.40267491340637207},{"id":"https://openalex.org/C121955636","wikidata":"https://www.wikidata.org/wiki/Q4116214","display_name":"Accounting","level":1,"score":0.3700186610221863},{"id":"https://openalex.org/C39549134","wikidata":"https://www.wikidata.org/wiki/Q133080","display_name":"Public relations","level":1,"score":0.3631211519241333},{"id":"https://openalex.org/C56739046","wikidata":"https://www.wikidata.org/wiki/Q192060","display_name":"Knowledge management","level":1,"score":0.33699339628219604},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.15578505396842957},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.15250766277313232},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.12488579750061035},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.1058715283870697},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.09704944491386414},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0},{"id":"https://openalex.org/C136764020","wikidata":"https://www.wikidata.org/wiki/Q466","display_name":"World Wide Web","level":1,"score":0.0},{"id":"https://openalex.org/C111472728","wikidata":"https://www.wikidata.org/wiki/Q9471","display_name":"Epistemology","level":1,"score":0.0},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2182578436","doi":null,"is_oa":false,"landing_page_url":"https://sites.duke.edu/sjpp/files/2014/02/Attard-ATMi.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.7246000170707703}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W99295644","https://openalex.org/W109965463","https://openalex.org/W120705993","https://openalex.org/W125529093","https://openalex.org/W227072212","https://openalex.org/W574765939","https://openalex.org/W586841314","https://openalex.org/W642279097","https://openalex.org/W1481162202","https://openalex.org/W1492076399","https://openalex.org/W1546145638","https://openalex.org/W1549710779","https://openalex.org/W1971702230","https://openalex.org/W2028780962","https://openalex.org/W2046558960","https://openalex.org/W2071920415","https://openalex.org/W2086118668","https://openalex.org/W2110502388","https://openalex.org/W2122047846","https://openalex.org/W2132816662","https://openalex.org/W2138525153","https://openalex.org/W2147631211","https://openalex.org/W2164351608","https://openalex.org/W2176065372","https://openalex.org/W2192642779","https://openalex.org/W2253978853","https://openalex.org/W2499596741","https://openalex.org/W2550291574","https://openalex.org/W3121227745","https://openalex.org/W3121378041"],"related_works":["https://openalex.org/W40783638","https://openalex.org/W4407796683","https://openalex.org/W2028557021","https://openalex.org/W3165025191","https://openalex.org/W4407799031","https://openalex.org/W2891567786","https://openalex.org/W2571761294","https://openalex.org/W2133137951","https://openalex.org/W2014086808","https://openalex.org/W2061752434"],"abstract_inverted_index":{"The":[0,51],"Access":[1,32],"to":[2,17,20,33,39,43,61,78,101],"Medicine":[3,34],"Index":[4],"(ATMi)":[5],"is":[6],"a":[7,26],"scorecard":[8],"framework":[9],"that":[10],"measures":[11],"the":[12,31,74,80,88,91],"efforts":[13],"of":[14,82,90],"pharmaceutical":[15,41,83],"companies":[16,42],"enhance":[18,102],"access":[19,60],"essential":[21,62],"medicines.":[22],"By":[23],"pro":[24],"viding":[25],"reliable":[27],"and":[28,98,106],"objective":[29],"appraisal,":[30],"Foundation":[35],"(ATMf":[36],")":[37],"hopes":[38],"encourage":[40],"increase":[44],"their":[45],"work":[46],"in":[47,64,93],"this":[48],"pivotal":[49],"area.":[50],"ATMi":[52,92],"could":[53],"represent":[54],"an":[55],"important":[56],"tool":[57],"for":[58],"improving":[59],"medicines":[63],"developing":[65],"countries":[66],"but":[67],"must":[68],"focus":[69],"more":[70],"on":[71],"optimally":[72],"engaging":[73,94],"diverse":[75],"stakeholders":[76],"necessary":[77],"shape":[79],"practices":[81],"companies.":[84],"This":[85],"study":[86],"evaluates":[87],"effectiveness":[89],"different":[95],"stakeholder":[96],"groups":[97],"provides":[99],"recommendations":[100],"its":[103],"influence,":[104],"credibility":[105],"objectivity.":[107]},"counts_by_year":[{"year":2015,"cited_by_count":2}],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2016-06-24T00:00:00"}